UNSPSC 51131629: Clopidogrel

This classification denotes a thienopyridine antiplatelet agent with the molecular formula C16H16ClNO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A74586SNO7, chemically known as thieno(3,2-c)pyridine-5(4h)-acetic acid, alpha-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (s)- but generally known as clopidogrel, which bears US NIH Compound Identifier 60606. European Medicines Agency schedules Clopidogrel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13395MIG.

UNSPSC 51131629 Clopidogrel is a Commodity code nominally identifying a specific antiplatelet pharmaceutical product, but the recent state and local procurement activity tagged under this code does not reflect pharmaceutical procurement. Sourcewell, a Minnesota local government cooperative unit, posted RFP #061626 on May 12, 2026 to establish a contracting solution for law enforcement equipment available to participating public entities across multiple states and Canada, with proposals due June 16, 2026. The solicitation scope, issuing structure, and intended use case bear no meaningful relationship to clopidogrel or pharmaceutical procurement generally. This code shows a taxonomy misalignment rather than active state and local procurement demand for the pharmaceutical product the code nominally describes.

The mismatch between the code name and the actual solicitation indicates that the Sourcewell opportunity was tagged incorrectly in the available records. No recent state and local procurement activity for clopidogrel or comparable antiplatelet drugs appears in the source material. Without additional opportunities grounded in the code's actual scope, the geographic spread, issuing-body mix, and market characterization for legitimate clopidogrel procurement cannot be determined from this source.